CDXS - Company ID 0001200375
CODEXIS, INC. trades as CDXS. In its fiscal 2025 annual report the company posted revenue of $70.39M, up 18.6% from the prior year and net income of -$43.97M. This page tracks CODEXIS, INC. through 989 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 9 fiscal years CODEXIS, INC.'s revenue grew from $48.84M to $70.39M, a compound annual growth rate of 4.1%. Net profit margin compressed from -17.5% to -62.5% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Quarterly report | 10-Q | 2026-05-07 |
| Major company event | 8-K | 2026-05-07 |
| SCHEDULE 13G/A | - | 2026-05-05 |
| Annual report to shareholders | ARS | 2026-04-28 |
| Proxy materials | DEFA14A | 2026-04-28 |
| Proxy statement | DEF 14A | 2026-04-28 |
| Major company event | 8-K | 2026-04-14 |
| SCHEDULE 13G | - | 2026-04-14 |
The largest companies sharing CODEXIS, INC.'s SEC industry classification (industrial organic chemicals).
CODEXIS, INC. reported revenue of $70.39M for fiscal year 2025, an increase of 18.6% year over year.
In its latest fiscal year CODEXIS, INC. reported a net loss of $43.97M.